Cheat Sheet: MDCG Guidance on Medical Device Classification

Published on:
April 8, 2022
Written by:
Hasma Boudaoui, Mercè Guerra, Ainoa Forteza

Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. The Medical Device Coordination Group (MDCG) (1) released guideline MDCG 2021-244 (2) in October, providing clarification on how medical devices (MDs) should be classified under the Medical Device Regulation (MDR) 2017/745.  

The MD manufacturer is responsible for assigning the proper classification to its MD, as it depends on the product’s claims and functionalities. Incorrectly classifying a MD could significantly impact product development, considering different regulatory, nonclinical, and clinical requirements depend on the classification.  

The MDCG issued this guidance to clarify the classification system under MDR and allow for easier comprehension of the MD classifications. The guidance includes a stepwise flowchart (3) illustrating how each rule should be applied and providing practical examples. 

MDCG Guidance – Medical Device Classes

In the EU, MDs are sorted into four different classes, from low to high risk:  

  • Class I 
  • Class IIa 
  • Class IIb 
  • Class III 

Classification is based on a risk level system that considers the degree of invasiveness, the part of the body affected, the contact duration with the body, and other elements. These elements, along with the intended use of the device, should help manufacturers determine which “classification rules” apply to their device.  

If more than one rule applies, the manufacturer should assign the highest risk class to the device. For example, if both Rule X (Class IIb) and Rule Y (Class III) apply to the device, the device would be assigned the higher one: Class III.  

If the regulatory classification of the device is not clear, or it could be controversial, Alira Health recommends seeking out clarification. Particularly with borderline products, e.g., products that could be seen as medicinal, cosmetics, or food supplements, clarification is important as not properly categorizing the product may have important consequences for its development. 

About Alira Health

The Alira Health Regulatory team provides support to manufacturers on: 

  • Properly classifying a device under MDR through a classification assessment that evaluates the MD’s intended use, target population, and functionality 
  • Identifying which requirements are applicable to your device based on the assigned class, and providing regulatory, operational, and strategic support to commercialize the product  

Learn more about our regulatory support.


  1. The Medical Device Coordination Group (MDCG) is an expert group, set up by both Medical Devices and In Vitro Diagnostic Devices regulations, respectively 2017/745 and 2017/746, whose members are representing EU competent authorities. Their main objective is to help and guide the European Commission and countries in implementing properly both regulations.
  2. MDCG 2021-24 Guidance on classification of medical devices mdcg_2021-24_en.pdf (
  3. MDCG 2021-24 Guidance on classification of medical devices. Explanations of individual rules: Graphical summary mdcg_2021-24_en.pdf (


  • MD: Medical Devices 
  • MDCG: Medical Device Coordination Group 
  • MDR: Medical Device Regulation 


Related news

News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
Events July 31, 2023
LSI Europe Emerging MedTech Summit
We will attend LSI Europe Emerging MedTech Summit in Barcelona to discuss the latest advancements, challenges, and trends in the industry.
MedTech Spain
News July 20, 2023
Diabetes Management Devices Market Trends 2023 is Released
Alira Health announced today the publication of the Diabetes Management Devices Market Trends 2023, in collaboration with MassMEDIC, the Massachusetts Medical Device Industry Council.
Diabetes MedTech
Blog July 20, 2023
Diabetes Management Devices Market Trends 2023: Executive Summary
Sneak peek at new report on the Diabetes Management Devices Market with insights including the trends, opportunities, and outlook for 2023.
Diabetes MedTech
Publications July 10, 2023
The EU Pharmaceutical Package: Regulatory Protection Changes
Our regulatory experts present a more detailed analysis of the proposed changes introduced to Regulatory Data Protection (RDP).
EU Pharma Regulatory
Blog June 30, 2023
Why You Need Market Access and How to Get Started
Start reading to learn about the importance of market access in pharma and MedTech and the key steps to get started.
Market Access MedTech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.